Stable Rates of Obstructive Hypertrophic Cardiomyopathy in a Contemporary Era
Frontiers in Cardiovascular Medicine, 2022 Hypertrophic cardiomyopathy is the most common genetic heart disease in the US, with an estimated prevalence of 1 in 500. However, the extent to which obstructive hypertrophic cardiomyopathy is clinically recognized is not well-established.
M. Butzner +5 more
semanticscholar +1 more source
High-Throughput Precision Phenotyping of Left Ventricular Hypertrophy with Cardiovascular Deep Learning [PDF]
, 2021 Left ventricular hypertrophy (LVH) results from chronic remodeling caused by a broad range of systemic and cardiovascular disease including hypertension, aortic stenosis, hypertrophic cardiomyopathy, and cardiac amyloidosis. Early detection and characterization of LVH can significantly impact patient care but is limited by under-recognition of ...
arxiv +1 more source
ESC Heart Failure, 2021 This study aimed to elucidate the long‐term effect of cibenzoline therapy on cardiovascular complications and prognosis in patients with hypertrophic obstructive cardiomyopathy (HOCM).
M. Hamada +4 more
semanticscholar +1 more source
Emerging Medical Treatment for Hypertrophic Cardiomyopathy [PDF]
, 2021 Hypertrophic cardiomyopathy (HCM) is a common myocardial disease characterized by otherwise unexplained left ventricular hypertrophy. The main cause of disabling symptoms in patients with HCM is left ventricular outflow tract (LVOT) obstruction.
Bacchi, Beatrice +9 more
core +1 more source
Journal of Clinical Medicine, 2021 Hypertrophic cardiomyopathy (HCM) is a complex, underestimated, multifaceted disease frequently associated with left ventricular outflow tract (LVOT) obstruction.
A. Affronti +6 more
semanticscholar +1 more source
Pattern and degree of left ventricular remodeling following a tailored surgical approach for hypertrophic obstructive cardiomyopathy. [PDF]
, 2012 Background The role of a tailored surgical approach for hypertrophic cardiomyopathy (HCM) on regional ventricular remodelling remains unknown. The aims of this study were to evaluate the pattern, extent and functional impact of regional ventricular ...
Cecchi, F +8 more
core +2 more sources
Age‐related survival after alcohol septal ablation in hypertrophic obstructive cardiomyopathy
ESC Heart Failure, 2021 Since its introduction, alcohol septal ablation (PTSMA) was discussed as treatment option only in elderly symptomatic patients with hypertrophic obstructive cardiomyopathy (HOCM). We report on long‐term follow‐up after PTSMA with respect to patient's age.
A. Batzner +4 more
semanticscholar +1 more source
Symptomatic Obstructive Hypertrophic Cardiomyopathy [PDF]
Circulation: Cardiovascular Interventions, 2013 Hypertrophic cardiomyopathy (HCM) is a common, yet challenging condition for clinical management. The majority of these patients have evidence of left ventricular outflow tract (LVOT) obstruction that may be asymptomatic or associated with debilitating symptoms of heart failure.
Paul Sorajja +2 more
openaire +3 more sources
Autosomal Dominant Polycystic Kidney Patients May Be Predisposed to Various Cardiomyopathies
Kidney International Reports, 2017 Mutations in PKD1 and PKD2 cause autosomal dominant polycystic kidney disease (ADPKD). Experimental evidence suggests an important role of the polycystins in cardiac development and myocardial function.
Fouad T. Chebib +10 more
doaj +1 more source
Association of PET-measured myocardial flow reserve with echocardiography-estimated pulmonary artery systolic pressure in patients with hypertrophic cardiomyopathy [PDF]
, 2019 BackgroundPulmonary hypertension (PH) is a known complication of HCM and is a strong predictor of mortality. We aim to investigate the relationship between microvascular dysfunction measured by quantitative PET and PH in HCM patients.MethodsEighty-nine ...
Leal, Jeffrey P +6 more
core +3 more sources